Context Capital reports 48.8M shares (9.9%) of Gossamer Bio
Gossamer Bio disclosed that Context Capital Management and related reporting persons collectively hold 48,835,788 shares of common stock, representing 9.9% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Gossamer Bio disclosed that Context Capital Management and related reporting persons collectively hold 48,835,788 shares of common stock, representing 9.9% of the class. The filing states the percentage is calculated using 488,846,722 shares outstanding as of June 5, 2026. The report clarifies the ownership cap in an agreement is 9.99% and shows shared voting and dispositive power over the reported shares.
Insights
Large passive stake disclosed: 48.8M shares (9.9%).
The filing lists 48,835,788 shares held collectively by Context Capital Management, Context Partners Master Fund and named control persons, with shared voting and dispositive power. The percentage basis is 488,846,722 shares outstanding as of June 5, 2026.
Future activity will depend on holder decisions and any contractual ownership limits; the filing notes an ownership limitation of 9.99%. Subsequent filings would show if disposition or additional disclosures follow.
Shared control structure and formal disclaimers are highlighted.
The report states LLC is general partner/adviser to the LP and names Rosen, Fertig and Carnegie as control persons, each disclaiming group membership and broader beneficial ownership beyond pecuniary interest. Shared voting/dispositive power is displayed rather than sole power.
Governance implications include that voting influence is aggregated via shared power; any changes to that aggregation would appear in amended filings or Section 13D disclosures if control intentions change.
Key Figures
Key Terms
Schedule 13G regulatory
beneficially owned regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Context Capital report in GOSS?
Who are the reporting persons named in the GOSS Schedule 13G?
Is there an ownership cap mentioned in the GOSS filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.